UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The burden of Cushing's disease: clinical and health-related quality of life aspects

European journal of endocrinology, 2012-09, Vol.167 (3), p.311

2012

Volltextzugriff (PDF)

Hypercoagulability in Cushing's syndrome: prevalence, pathogenesis and treatment

Clinical endocrinology (Oxford), 2013-04, Vol.78 (4), p.481-488

2013

Volltextzugriff (PDF)

Risk Factors for Hemodynamic Instability during Surgery for Pheochromocytoma

The journal of clinical endocrinology and metabolism, 2010-02, Vol.95 (2), p.678-685

2010

Volltextzugriff (PDF)

Differentiating between Cushing's disease and pseudo-Cushing's syndrome: comparison of four tests

European journal of endocrinology, 2014-04, Vol.170 (4), p.477-486

2014

Volltextzugriff (PDF)

Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection

European journal of endocrinology, 2013-09, Vol.169 (3), p.263-270

2013

Volltextzugriff (PDF)

Future directions in the diagnosis and medical treatment of adrenocortical carcinoma

Endocrine-related cancer, 2016-01, Vol.23 (1), p.R43-R69

2016

Volltextzugriff (PDF)

Current clinical practice for thromboprophylaxis management in patients with Cushing's syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN)

Orphanet journal of rare diseases, 2022-05, Vol.17 (1), p.178-178, Article 178

2022

Volltextzugriff (PDF)

Long-Term Efficacy and Safety of Pegvisomant in Combination With Long-Acting Somatostatin Analogs in Acromegaly

The journal of clinical endocrinology and metabolism, 2014-10, Vol.99 (10), p.3644-3652

2014

Volltextzugriff (PDF)

Incidence of Venous Thromboembolism in Patients with Cushing's Syndrome: A Multicenter Cohort Study

The journal of clinical endocrinology and metabolism, 2011-11, Vol.96 (11), p.3525-3532

2011

Volltextzugriff (PDF)

A Novel Tool in the Diagnosis and Follow-Up of (Cyclic) Cushing's Syndrome: Measurement of Long-Term Cortisol in Scalp Hair

The journal of clinical endocrinology and metabolism, 2012-10, Vol.97 (10), p.E1836-E1843

2012

Volltextzugriff (PDF)

Fluconazole inhibits human adrenocortical steroidogenesis in vitro

Journal of endocrinology, 2012-12, Vol.215 (3), p.403-412

2012

Volltextzugriff (PDF)

Combined treatment for acromegaly with long-acting somatostatin analogs and pegvisomant: long-term safety for up to 4.5 years (median 2.2 years) of follow-up in 86 patients

European journal of endocrinology, 2009-04, Vol.160 (4), p.529-533

2009

Volltextzugriff (PDF)

The Hypercoagulable State in Cushing's Disease Is Associated with Increased Levels of Procoagulant Factors and Impaired Fibrinolysis, But Is Not Reversible after Short-Term Biochemical Remission Induced by Medical Therapy

The journal of clinical endocrinology and metabolism, 2012-04, Vol.97 (4), p.1303-1310

2012

Volltextzugriff (PDF)

Improved Control of Severe Hypoglycemia in Patients with Malignant Insulinomas by Peptide Receptor Radionuclide Therapy

The journal of clinical endocrinology and metabolism, 2011-11, Vol.96 (11), p.3381-3389

2011

Volltextzugriff (PDF)

Combined therapy with somatostatin analogues and weekly pegvisomant in active acromegaly

The Lancet (British edition), 2005-05, Vol.365 (9471), p.1644-1646

2005

Volltextzugriff (PDF)

Quality of Life in Acromegalic Patients during Long-Term Somatostatin Analog Treatment with and without Pegvisomant

The journal of clinical endocrinology and metabolism, 2008-10, Vol.93 (10), p.3853-3859

2008

Volltextzugriff (PDF)

Inhibition of Human Adrenocortical Cancer Cell Growth by Temozolomide in Vitro and the Role of the MGMT Gene

The journal of clinical endocrinology and metabolism, 2016-12, Vol.101 (12), p.4574-4584

2016

Volltextzugriff (PDF)

Preoperative Normalization of Cortisol Levels in Cushing's Disease After Medical Treatment: Consequences for Somatostatin and Dopamine Receptor Subtype Expression and In Vitro Response to Somatostatin Analogs and Dopamine Agonists

The journal of clinical endocrinology and metabolism, 2013-12, Vol.98 (12), p.E1880-E1890

2013

Volltextzugriff (PDF)

Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA0, Tyr3]octreotate

European journal of nuclear medicine and molecular imaging, 2003-03, Vol.30 (3), p.417-422

2003

Volltextzugriff (PDF)

Venous thromboembolism in Cushing syndrome: results from an EuRRECa and Endo-ERN survey

Endocrine Connections, 2024, Vol.13 (6), p.1-10

2024

Volltextzugriff (PDF)

Somatostatin and dopamine receptors as targets for medical treatment of Cushing's Syndrome

Reviews in endocrine & metabolic disorders, 2009-06, Vol.10 (2), p.91-102

2009

Volltextzugriff (PDF)

Mifepristone Effects on Tumor Somatostatin Receptor Expression in Two Patients with Cushing's Syndrome due to Ectopic Adrenocorticotropin Secretion

The journal of clinical endocrinology and metabolism, 2012-02, Vol.97 (2), p.455-462

2012

Volltextzugriff (PDF)

Salvage peptide receptor radionuclide therapy with [177Lu-DOTA,Tyr3]octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumours

European journal of nuclear medicine and molecular imaging, 2019-03, Vol.46 (3), p.704-717

2019

Volltextzugriff (PDF)

Epigenetic regulation of somatostatin and somatostatin receptors in neuroendocrine tumors and other types of cancer

Reviews in endocrine & metabolic disorders, 2021-09, Vol.22 (3), p.495-510

2021

Volltextzugriff (PDF)

Selective Glucocorticoid Receptor Modulators: Future of Glucocorticoid Immunosuppressive Therapy?

Endocrinology (Philadelphia), 2011-08, Vol.152 (8), p.2927-2929

2011

Volltextzugriff (PDF)

1 – 25 von 262

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(194)
Mit Volltextzugriff
(197)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(161)
Life Sciences & Biomedicine
(145)
Humans
(124)
Endocrinology & Metabolism
(86)
Female
(84)
Male
(83)
Middle Aged
(78)
Adult
(72)
Aged
(60)
Biological And Medical Sciences
(53)
Medical Sciences
(48)
Endocrinopathies
(38)
Fundamental And Applied Biological Sciences. Psychology
(38)
Vertebrates: Endocrinology
(35)
Computer Science
(29)
Technology
(29)
Non Tumoral Diseases. Target Tissue Resistance. Benign Neoplasms
(27)
Computer Science, Information Systems
(26)
Treatment Outcome
(24)
Somatostatin - Analogs & Derivatives
(22)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

The burden of Cushing's disease: clinical and health-related quality of life aspects

Hypercoagulability in Cushing's syndrome: prevalence, pathogenesis and treatment

Risk Factors for Hemodynamic Instability during Surgery for Pheochromocytoma

Differentiating between Cushing's disease and pseudo-Cushing's syndrome: comparison of four tests

Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection

Future directions in the diagnosis and medical treatment of adrenocortical carcinoma

Current clinical practice for thromboprophylaxis management in patients with Cushing's syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN)

Long-Term Efficacy and Safety of Pegvisomant in Combination With Long-Acting Somatostatin Analogs in Acromegaly

Incidence of Venous Thromboembolism in Patients with Cushing's Syndrome: A Multicenter Cohort Study

A Novel Tool in the Diagnosis and Follow-Up of (Cyclic) Cushing's Syndrome: Measurement of Long-Term Cortisol in Scalp Hair

Fluconazole inhibits human adrenocortical steroidogenesis in vitro

Combined treatment for acromegaly with long-acting somatostatin analogs and pegvisomant: long-term safety for up to 4.5 years (median 2.2 years) of follow-up in 86 patients

The Hypercoagulable State in Cushing's Disease Is Associated with Increased Levels of Procoagulant Factors and Impaired Fibrinolysis, But Is Not Reversible after Short-Term Biochemical Remission Induced by Medical Therapy

Improved Control of Severe Hypoglycemia in Patients with Malignant Insulinomas by Peptide Receptor Radionuclide Therapy

Combined therapy with somatostatin analogues and weekly pegvisomant in active acromegaly

Quality of Life in Acromegalic Patients during Long-Term Somatostatin Analog Treatment with and without Pegvisomant

Inhibition of Human Adrenocortical Cancer Cell Growth by Temozolomide in Vitro and the Role of the MGMT Gene

Preoperative Normalization of Cortisol Levels in Cushing's Disease After Medical Treatment: Consequences for Somatostatin and Dopamine Receptor Subtype Expression and In Vitro Response to Somatostatin Analogs and Dopamine Agonists

Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA0, Tyr3]octreotate

Venous thromboembolism in Cushing syndrome: results from an EuRRECa and Endo-ERN survey

Somatostatin and dopamine receptors as targets for medical treatment of Cushing's Syndrome

Mifepristone Effects on Tumor Somatostatin Receptor Expression in Two Patients with Cushing's Syndrome due to Ectopic Adrenocorticotropin Secretion

Salvage peptide receptor radionuclide therapy with [177Lu-DOTA,Tyr3]octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumours

Epigenetic regulation of somatostatin and somatostatin receptors in neuroendocrine tumors and other types of cancer

Selective Glucocorticoid Receptor Modulators: Future of Glucocorticoid Immunosuppressive Therapy?

Suchergebnisse filtern